Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Nature|February 24, 2012
Structural basis of highly conserved ribosome recycling in eukaryotes and archaeaThomas Becker, Sibylle Franckenberg, Stephan Wickles, et al.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
Viruses|May 27, 2026
Dynamic Changes in Host Immune Response During Crimean-Congo Hemorrhagic Fever and Severe Fever with Thrombocytopenia Syndrome in MiceDoreswamy Kenchegowda, Brian D Carey, Joshua Shamblin, et al.
Plos Neglected Tropical Diseases|September 19, 2017
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse modelsAura R Garrison, Charles J Shoemaker, Joseph W Golden, et al.
Science Advances|July 17, 2019
GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infectionJoseph W Golden, Charles J Shoemaker, Michael E Lindquist, et al.
Viruses|January 8, 2025
A Small-Particle Aerosol Model of Ebolavirus Zaire Infection in FerretsCourtney A Cohen, Elizabeth E Zumbrun, James V Writer, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
Plos Pathogens|September 27, 2019
Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosisDarci R Smith, Charles J Shoemaker, Xiankun Zeng, et al.
Microorganisms|April 3, 2021
Transcriptomic Analysis Reveals Host miRNAs Correlated with Immune Gene Dysregulation during Fatal Disease Progression in the Ebola Virus Cynomolgus Macaque Disease ModelChristopher P Stefan, Catherine E Arnold, Charles J Shoemaker, et al.
Antiviral Research|April 1, 2023
Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamstersYu Cong, Eric M Mucker, Donna L Perry, et al.
Pageof 17